Ken Griffin Gossamer Bio, Inc. Put Options Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
Put Options
12 transactions
Others Institutions Holding GOSS
# of Institutions
136Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$35.4 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$34.9 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$22 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$15.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$13.8 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $181M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...